Home NDC 42858-080-45 Methylphenidate Hydrochloride
Product NDC 42858-080
Requested package NDC 42858-080-45
11-digit product format 428580080
Labeler code 42858
Product ID 42858-080_dd7e2d15-d45e-41dc-9d9a-7b68c229b601
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Methylphenidate Hydrochloride
Dosage form CAPSULE, EXTENDED RELEASE
Route ORAL
Labeler Rhodes Pharmaceuticals LLC
Application NDA205831
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2020-04-01
Substance METHYLPHENIDATE HYDROCHLORIDE
Active strength 50 mg/1
Pharmacologic classes Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
DEA schedule CII
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205831-001 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-002 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-003 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-004 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-005 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-006 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-007 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 7 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 8 · 315 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 c2088c7a36db…2026-09-14 22:38:34 2026-08 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…
Observed Orange Book normalized TE history# Normalized TE history page 4 of 8 · 315 observed states.
Observed Orange Book patent history# Patent history page 1 of 15 · 567 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N205831-001 10039719 2019-12-16 U-2357 2018-08-15 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 6419960 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7083808 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7247318 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7438930 2019-12-16 Drug product, Delist requested 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 8580310 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 9066869 2019-12-16 Drug product 2015-07-27 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 9801823 2019-12-16 Drug product 2017-11-29 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 10039719*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 6419960*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7083808*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7247318*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7438930*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 8580310*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 9066869*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 9801823*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 10039719 2019-12-16 U-2357 2018-08-15 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 6419960 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7083808 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7247318 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7438930 2019-12-16 Drug product, Delist requested 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 8580310 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 9066869 2019-12-16 Drug product 2015-07-27 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 9801823 2019-12-16 Drug product 2017-11-29 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 10039719*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 6419960*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7083808*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7247318*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7438930*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 8580310*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 9066869*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 9801823*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 10039719 2019-12-16 U-2357 2018-08-15 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 6419960 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 7083808 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 7247318 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 7438930 2019-12-16 Drug product, Delist requested 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 8580310 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 9066869 2019-12-16 Drug product 2015-07-27 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 9801823 2019-12-16 Drug product 2017-11-29 74a2ff9319b5…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Methylphenidate Hydrochloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength METHYLPHENIDATE HYDROCHLORIDE 50 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 4B3SC438HI Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 7 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1648183 Internal RxNorm lookup 1806200 Internal RxNorm lookup 1806202 Internal RxNorm lookup 1806204 Internal RxNorm lookup 1806206 Internal RxNorm lookup 1806208 Internal RxNorm lookup 1806210 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42858-080-45 Methylphenidate Hydrochloride 90 in 1 BOTTLE CAPSULE, EXTENDED RELEASE 90 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42858-080 METHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS] 5 Current NDC, Legacy NDC, 1 package rows 20231108_f7a7ffd1-bc30-4db8-8391-dddf76acd639.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 42858-080-45 42858008045 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42858-080-45) 2020-04-01 0000-00-00 No No Current